| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.34 | 0.03 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |